http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2330655-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9494c30f8f6cb9e15dc21e0d6895855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8ee484f4ba9a0406b8927b5be6c4f2a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H1-00
filingDate 2006-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d82f9b0cf4e798907ff513c96a17780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f99e05e74eab6792b83e8ff9939c2e
publicationDate 2008-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2330655-C1
titleOfInvention Method of thromboxane-formation normalisation for patients suffering form arterial hypertension associated with metabolic syndrome
abstract FIELD: medicine; cardiology. n SUBSTANCE: in case patient is diagnosed with increased thromboxane development resulted from three transfer tests while level of thrombocyte aggregation restoration within simple transfer test is higher than 37.0%, indicators of collagen-aspirin test are higher than 69.0% and/or of collagen-imidazole test is higher than 59%, for purposes of thromboxane development correction associated with arterial hypertension and metabolic syndrome, low-calorie diet, graduated physical activity, intake of Lovastatin 20 mg for the night and Amlodipine 10 mg once a day are prescribed for patient within 4 months. n EFFECT: provided normalisation of thromboxane formation in thrombocytes. n 1 tbl, 3 ex
priorityDate 2006-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1LIA5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2PG45
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2KIG5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566278
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49430
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584573
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20849128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ96SQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47787
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9DBX6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546850
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839

Total number of triples: 48.